"Extracts from Rabbit Skin Inflamed by Vaccinia Virus for Injection" (lizaishi) is a therapeutic biological product containing a variety of globally patented biological small molecular peptides. It can relieve a variety of symptoms of symptomatic neuralgia or neuropathic pain. Due to its analgesic effect and unique curative effect, it has been widely recognized and applied in China.

After more than 20 years of research and development and clinical verification, it was found that this product is a drug that can regenerate neurons and reduce the injury of the inflammatory body, and has significant curative effect on various central and peripheral nerve injury diseases.

"Extracts from rabbit skin inflamed by vaccine virus for injection" is a therapeutic biological product produced by Vanworld Pharmaceutical (Rugao) Company Limited. It was approved by the State Food and Drug Administration (CFDA) (gyzz s20040022) in 2004 and began to be produced and sold in China. Clinically, it is mainly used for the treatment of "neck, shoulder and wrist syndrome; relief of pain, cold sensation, numbness and other symptoms of patients with low back pain; symptomatic neuralgia".

In the clinical use, it was found that the product not only has significant curative effect on neuropathic pain and numbness caused by nervous system injury, but also attracts much attention in the medical community because of its regulatory effect on the immune system.

The main efficacy of "extracts from rabbit skin inflamed by vaccine virus for injection" (lizaishi): it can effectively promote the proliferation of neural stem cells (NSCs), effectively regulate the polarization of microglia from M1 to m2, effectively increase the number of neurons, effectively regulate the body's immune response, significantly reduce the body's response caused by inflammation, and reduce the number of inflammatory cells.

Clinical experts recommend it for orthopedics, neurology, pain, anesthesiology, endocrinology, dermatology, oncology and nephrology.